Natixis Dr Reddys Laboratories LTD Transaction History

Natixis

$17.4 Billion
Q2 2024

A detailed history of Natixis transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Natixis holds 567 shares of RDY stock, worth $45,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares

567

Previous 567 -0.0%

Holding current value

$45,048

Previous $41,000 4.88%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$53.34 - $63.11 $7,680 - $9,087	-144 Reduced 20.25%	567 $35,000
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $36,708 - $40,477	711 New	711 $40,000
Q4 2020 Feb 12, 2021	SELL	$62.61 - $71.29 $2.45 Million - $2.79 Million	-39,200 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$51.39 - $72.41 $4 Million - $5.64 Million	-77,822 Reduced 66.5%	39,200 $2.73 Million
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $6.8 Million - $9.4 Million	-171,978 Reduced 59.51%	117,022 $6.2 Million
Q1 2020 May 14, 2020	SELL	$34.75 - $45.85 $4.63 Million - $6.11 Million	-133,260 Reduced 31.56%	289,000 $11.7 Million
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $183,299 - $208,900	-5,000 Reduced 1.17%	422,260 $17.2 Million
Q3 2019 Nov 13, 2019	BUY	$34.82 - $39.26 $195,514 - $220,444	5,615 Added 1.33%	427,260 $16.2 Million
Q2 2019 Aug 13, 2019	BUY	$36.05 - $42.76 $15.2 Million - $18 Million	421,645 New	421,645 $15.8 Million
Q2 2018 Aug 14, 2018	SELL	$28.49 - $35.06 $198,774 - $244,613	-6,977 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$31.93 - $39.54 $222,775 - $275,870	6,977 New	6,977 $228,000
Q4 2017 Feb 14, 2018	SELL	$34.15 - $37.62 $830,971 - $915,407	-24,333 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $732,666 - $917,840	24,333	24,333 $868,000

Others Institutions Holding RDY

# of Institutions

233

Shares Held

24M

Call Options Held

14.6K

Put Options Held

2.8K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account